SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PawPr who wrote (116)6/7/1997 10:04:00 AM
From: Thean   of 965
 
Bruce, do you know what are the expectations we can have out of the study data? I remember your telling us that this is going to be the release of a phase II study data. What is the indication here that the study was geared for? For phase II result, without knowing much detail, I would expect tolerance and maybe dose-ranging results. Shall we expect efficacy result here? Please fill us in if you know what to expect from this meeting. Thanks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext